Rockefeller Capital Management
FOLD

Rockefeller Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Rockefeller Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.8K Buy
1,786
+324
+22% +$4.64K ﹤0.01% 3592
2025
Q4 		$20.8K Buy
1,462
+102
+8% +$1K ﹤0.01% 3501
2025
Q3 		$10.7K Buy
+1,360
New +$9.68K ﹤0.01% 3620
2023
Q1 		– Sell
-300
Closed -$3K – 2663
2022
Q4 		$3K Sell
300
-680
-69% -$7.66K ﹤0.01% 3460
2022
Q3 		$10K Sell
980
-146
-13% -$1.63K ﹤0.01% 3082
2022
Q2 		$12K Sell
1,126
-268
-19% -$2.21K ﹤0.01% 3009
2022
Q1 		$13K Sell
1,394
-755
-35% -$7.08K ﹤0.01% 2913
2021
Q4 		$24K Buy
2,149
+1,004
+88% +$11.2K ﹤0.01% 2558
2021
Q3 		$10K Sell
1,145
-69
-6% -$706 ﹤0.01% 2887
2021
Q2 		$11K Buy
1,214
+1,049
+636% +$10.2K ﹤0.01% 2738
2021
Q1 		$1K Sell
165
-883
-84% -$13.7K ﹤0.01% 3172
2020
Q4 		$24K Sell
1,048
-9,191
-90% -$188K ﹤0.01% 1931
2020
Q3 		$143K Buy
10,239
+858
+9% +$12.5K ﹤0.01% 1151
2020
Q2 		$142K Sell
9,381
-33
-0.4% -$402 ﹤0.01% 1050
2020
Q1 		$87K Sell
9,414
-3,086
-25% -$29.3K ﹤0.01% 1057
2019
Q4 		$122K Sell
12,500
-2,050
-14% -$18.8K ﹤0.01% 910
2019
Q3 		$117K Buy
14,550
+2,992
+26% +$32.5K ﹤0.01% 747
2019
Q2 		$144K Buy
11,558
+11,495
+18,246% +$146K ﹤0.01% 632
2019
Q1 		$1K Buy
+63
New +$770 ﹤0.01% 1852
2018
Q3 		– Sell
-19,169
Closed -$299K – 767
2018
Q2 		$299K Hold
19,169
– – ﹤0.01% 304
2018
Q1 		$288K Buy
+19,169
New +$292K ﹤0.01% 305

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rockefeller Capital Management's FOLD Position: Q1 2026 in Review

Rockefeller Capital Management increased its Amicus Therapeutics (FOLD) stake by 22% in Q1 2026, buying an estimated $4.64K and bringing the position to 1,786 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3592.

Rockefeller Capital Management first reported a position in FOLD in Q1 2018 and has held it in 21 quarters since. The position peaked at $299K in Q2 2018. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Rockefeller Capital Management held 1,786 shares of Amicus Therapeutics worth $25.8K as of Q1 2026.
  • Rockefeller Capital Management bought 324 Amicus Therapeutics shares in Q1 2026, an estimated $4.64K.
  • Amicus Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3592 holding.
  • Rockefeller Capital Management first reported a position in Amicus Therapeutics in Q1 2018 and has held it in 21 quarters since.
  • Rockefeller Capital Management's Amicus Therapeutics position peaked at $299K in Q2 2018.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.